This site is intended for healthcare professionals

FIDELIO-DKD Phase III study of BAY 94 8862 in CKD + T2D published in Circulation.- Bayer

Read time: 1 mins
Last updated:18th Nov 2020
Published:18th Nov 2020
Condition: Diabetes Type 2 and Kidney Disease
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest